Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

A, Camperdown N Clinical Trials

A listing of A, Camperdown N clinical trials actively recruiting patients volunteers.

RESULTS

Found (1049) clinical trials

Gotta Go, Gotta go. Research Study for Overactive Bladder at Medical Center for Clinical Research

Phase N/A

Concerned about what Rosacea is doing to your skin? Medical Center for Clinical Research is enrolling volunteers with moderate to severe rosacea in a study testing an investigational medication.

Phase N/A

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

Phase

A phase 3 study that evaluates the safety and effectiveness of Elagolix in combination with the naturally produced hormone Estradiol for subjects with moderate to severe Endometriosis associated pain.

Phase

A research study is evaluating an investigational quadrivalent meningococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants.

Phase N/A

Unhappy with your options for eczema? Considering different options? Wake Research is enrolling volunteers in a study of the efficacy, safety and tolerability of an investigational ointment for mild to moderate eczema, also called atopic dermatitis. Your participation in the study could last up to three months. You’ll receive study-related ...

Phase N/A

The objective of the study is to evaluate the safety and efficacy of ONZETRA Xsail (AVP-825) compared to placebo in the acute treatment of migraine in adolescent patients, 12 through 17 years of age.

Phase

Do You Get GERD Despite Being on PPIs? Carolina’s GI Research is conducting a research study for patients with Gastroesophageal Reflux Disease (GERD) who are still experiencing symptoms while on Proton Pump Inhibitors (PPIs).

Phase N/A

This is a Phase 3, dose-escalation study designed to evaluate the safety and efficacy of both elagolix 150 mg QD and elagolix 200 mg BID plus E2/NETA (1 mg/0.5 mg) QD over 24 months in the management of endometriosis with associated moderate to severe pain in premenopausal women.

Phase

The purpose of the Stroke AF study is to compare the incidence of atrial fibrillation (AF) through 12 months between continuous cardiac rhythm monitoring with the Reveal LINQ™ Insertable Cardiac Monitor (ICM) (continuous monitoring arm) and standard of care (SoC) medical treatment (control arm) in subjects with a recent ischemic ...

Phase N/A